Search

You searched for "therapeutics"

496 results found

I saw it on the internet: gathering evidence for clinical decision making

4 September 2023 | | ENTA - Speech and Language Therapy
Evidence-based practice is often described as the integration of three sources of information to inform clinical practice, namely: 1) research evidence/practice guidelines; 2) client preferences/needs, and: 3) clinical experience. Speech and language therapists have reported a lack of time and...

Rask-Andersen made honorary member of ENT UK

25 April 2022 |
The inner-ear research laboratory at the University of Uppsala in Sweden has a long tradition of ear research. The department has been linked to such legendary names as Barany (Nobel Laureate), Nylen and Stahle. Now, the head of that department, Professor Helge Rask-Andersen, has been awarded honorary membership of ENT UK.

Diagnosis and treatment of snoring in adults – S2k Guideline of the German Society of Otorhinolaryngology, Head and Neck Surgery

1 May 2015 |
This article summarises the work done by the German Society of Otorhinolaryngology, who have developed guidelines for the management of snoring. ‘S2k’ is German nomenclature for a consensus based guideline, which (for those of you interested in such things), is...
Otolaryngology - Head and Neck Surgery journal front cover image

Treatment of internal carotid artery blowout with embolisation and bypass grafting (nasopharyngeal carcinoma)

6 September 2021 | | ENTA - Head & Neck, ENTA - Skull Base Surgery | bypass, carotid blowout syndrome, embolization, head and neck cancer, oral and nasal massive hemorrhage
Carotid artery blowout syndrome (CBS) occurs when there is rupture of the carotid artery causing massive epistaxis and bleeding through the oral cavity caused by tumour invasion, surgery, radiotherapy, or infection. This article proposes a revascularisation strategy for internal carotid...

Metformin, the magical solution!

8 January 2024 | | ENTA - Neurotology
Both noise-induced hearing loss (NIHL) and vestibular schwannomas (VSs) pose a challenge in terms of management. Metformin was suggested as a potential therapeutic drug for NIHL when the drug-target interaction data was investigated. Additionally, there are studies which demonstrate reduction...

Recurrent respiratory papilloma treatment in the office

1 September 2018 | | ENTA - Laryngology / Swallowing / Voice
In this interesting new article, Markus Hess and Susanne Fleischer describe their technique for managing recurrent laryngeal papillomatosis in an outpatient setting using channelled endoscopes. The recurrent respiratory papillomatosis (RRP) of the larynx is a chronic HPV-associated viral disease. Clinical...

Cyclops Medtech partners with Hypatia Specialist Clinics

30 October 2021 | Company Profiles, Contracts & Distributors
Cyclops Medtech is partnering with Hypatia Specialist Clinics to provide vestibular diagnostic and therapeutic solutions throughout the United Kingdom and parts of Europe.

Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms

7 July 2022 | Research & Development
Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.

In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness

2 September 2022 | | ENTA - Auditory Implants, ENTA - Audiology - Diagnostic, ENTA - Audiology - Adult, ENTA - Otology
Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...

OTC hearing aids: where are we now?

2 September 2022 | ENTA - Audiology - Adult
The ‘Over-the-Counter Hearing Aid Act’ of 2017 set in motion plans for a long-debated shift in the hearing care market. In 2021, the FDA released draft guidance which will allow hearing aids in the US to be sold direct to...

Getting started in research

10 March 2023 | | ENTA - Audiology - Adult
Dave had a passion for research and was very encouraging in developing a research interest in others. Bhavisha and Amanda are currently working with a team of researchers, patients, research funders, the Department of Health and Social Care and NHS England, to develop the 2023-2028 UK Action Plan for Hearing loss and Tinnitus Research - a set of recommendations to grow hearing research in the UK. Here, they discuss their journey to hearing care research and how you could get involved in the world of research.

Lenire as a clinical tool for treatment of tinnitus

2 May 2025 | | ENTA - Audiology - Adult, ENTA - Tinnitus
Lenire offers a promising but varied solution for tinnitus relief. Peter Byrom shares insights on its effectiveness, challenges and patient outcomes. I have been involved in tinnitus support for at least 20 years, including a stint on the then British...